TSS
Two Sigma Securities’s Regeneron Pharmaceuticals REGN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.03M | Buy |
1,968
+1,024
| +108% | +$538K | 0.13% | 198 |
|
|
2025
Q1 | $599K | Sell |
944
-550
| -37% | -$349K | 0.09% | 285 |
|
|
2024
Q4 | $1.06M | Sell |
1,494
-206
| -12% | -$147K | 0.14% | 98 |
|
|
2024
Q3 | $1.79M | Buy |
+1,700
| New | +$1.79M | 0.03% | 145 |
|
|
2024
Q2 | – | Hold |
0
| – | – | – | 2043 |
|
|
2024
Q1 | – | Sell |
-7,967
| Closed | -$7M | – | 2015 |
|
|
2023
Q4 | $7M | Buy |
7,967
+7,681
| +2,686% | +$6.75M | 0.07% | 58 |
|
|
2023
Q3 | $235K | Sell |
286
-4,287
| -94% | -$3.53M | ﹤0.01% | 727 |
|
|
2023
Q2 | $3.29M | Sell |
4,573
-1,490
| -25% | -$1.07M | 0.05% | 66 |
|
|
2023
Q1 | $4.98M | Buy |
+6,063
| New | +$4.98M | 0.1% | 47 |
|
|
2022
Q4 | – | Sell |
-1,171
| Closed | -$807K | – | 1883 |
|
|
2022
Q3 | $807K | Sell |
1,171
-99
| -8% | -$68.2K | 0.02% | 216 |
|
|
2022
Q2 | $751K | Sell |
1,270
-4,375
| -78% | -$2.59M | 0.03% | 190 |
|
|
2022
Q1 | $3.94M | Buy |
5,645
+3,034
| +116% | +$2.12M | 0.14% | 28 |
|
|
2021
Q4 | $1.65M | Buy |
2,611
+1,850
| +243% | +$1.17M | 0.07% | 56 |
|
|
2021
Q3 | $461K | Sell |
761
-493
| -39% | -$299K | 0.01% | 274 |
|
|
2021
Q2 | $700K | Buy |
1,254
+161
| +15% | +$89.9K | 0.02% | 130 |
|
|
2021
Q1 | $517K | Sell |
1,093
-441
| -29% | -$209K | 0.03% | 139 |
|
|
2020
Q4 | $741K | Buy |
1,534
+866
| +130% | +$418K | 0.02% | 93 |
|
|
2020
Q3 | $374K | Sell |
668
-6
| -0.9% | -$3.36K | 0.01% | 196 |
|
|
2020
Q2 | $420K | Buy |
+674
| New | +$420K | 0.01% | 192 |
|
|
2020
Q1 | – | Sell |
-1,032
| Closed | -$387K | – | 1160 |
|
|
2019
Q4 | $387K | Sell |
1,032
-3,629
| -78% | -$1.36M | ﹤0.01% | 322 |
|
|
2019
Q3 | $1.29M | Buy |
4,661
+3,680
| +375% | +$1.02M | 0.01% | 105 |
|
|
2019
Q2 | $307K | Buy |
+981
| New | +$307K | ﹤0.01% | 405 |
|
|
2019
Q1 | – | Sell |
-2,397
| Closed | -$895K | – | 1350 |
|
|
2018
Q4 | $895K | Sell |
2,397
-3,209
| -57% | -$1.2M | 0.01% | 154 |
|
|
2018
Q3 | $2.27M | Sell |
5,606
-680
| -11% | -$275K | 0.01% | 63 |
|
|
2018
Q2 | $2.17M | Buy |
6,286
+3,209
| +104% | +$1.11M | 0.01% | 115 |
|
|
2018
Q1 | $1.06M | Buy |
3,077
+2,172
| +240% | +$748K | 0.01% | 266 |
|
|
2017
Q4 | $340K | Sell |
905
-134
| -13% | -$50.3K | 0.01% | 360 |
|
|
2017
Q3 | $465K | Buy |
1,039
+279
| +37% | +$125K | 0.04% | 260 |
|
|
2017
Q2 | $373K | Buy |
+760
| New | +$373K | 0.07% | 275 |
|
|
2016
Q4 | – | Sell |
-627
| Closed | -$252K | – | 900 |
|
|
2016
Q3 | $252K | Buy |
+627
| New | +$252K | 0.09% | 343 |
|
|
2016
Q1 | – | Sell |
-505
| Closed | -$274K | – | 373 |
|
|
2015
Q4 | $274K | Buy |
+505
| New | +$274K | 0.33% | 71 |
|